Gene Panel Market Trends

  • Report ID: 3634
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Gene Panel Market Trends

Growth Drivers

  • Advancement in Genetic Biotechnology
  • Increasing Incidences of Cancer and Genetic Disorders
  • Ongoing Research and Development Activities

Challenges

  • Lack of Workforce in Biotechnological Research
  • Lack of Health Awareness in Low and Middle-income Countries

Gene Panel Market: Key Insights

Healthcare

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Base Year

2024

Forecast Year

2025-2037

CAGR

18.4%

Base Year Market Size (2024)

USD 3.56 billion

Forecast Year Market Size (2037)

USD 31.99 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3634
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of gene panel is assessed at USD 4.12 billion.

Gene Panel Market size was valued at USD 3.56 billion in 2024 and is expected to reach USD 31.99 billion by 2037, registering around 18.4% CAGR during the forecast period i.e., between 2025-2037.

Middle East and Africa industry is estimated to hold largest revenue share by 2037, propelled by rising cases of genetic diseases in the region, led by lack of proper nutrition and care during pregnancy, and presence of carcinogens in the immediate surroundings.

The major players in the market are Illumina, Inc., BGI Group, Agilent Technologies, Inc., Eurofins Scientific, QIAGEN, GENEWIZ Japan Corp., Novogene Corporation, F. Hoffmann-La Roche AG, Personalis Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample